Aptahem AB (publ) (NGM:APTA)
Sweden
· Delayed Price · Currency is SEK 0.878
-0.008 (-0.90%)
At close: Mar 6, 2026
Aptahem AB Revenue
In the year 2025, Aptahem AB had annual revenue of 2.59M SEK, down -31.47%. Aptahem AB had revenue of 829.00K in the quarter ending December 31, 2025, a decrease of -64.84%.
Revenue
2.59M
Revenue Growth
-31.47%
P/S Ratio
7.55
Revenue / Employee
861.67K
Employees
3
Market Cap
19.50M
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| ExpreS2ion Biotech Holding AB | 10.85M |
| Novakand Pharma AB | 14.00K |
| Fluicell AB | 15.22M |
| NanoEcho AB | 487.00K |
| Stayble Therapeutics AB | 47.00K |
| Nanologica AB | 21.13M |
| 2cureX AB | 1.98M |
| AcouSort AB | 10.43M |